-
24 June 2025 23:03:06
- Source: Sharecast
Spire Healthcare Group plc (the "Company")
24 June 2025
Notification of Transactions of Persons Discharging Managerial Responsibilities
Exercise of Sharesave (SAYE) Plan options
The Company announces the following changes to the interests of the Executive Directors listed below in the Company's ordinary shares of 1 pence each (the "Shares").
On 1 June 2025, the options granted on 26 April 2022 under the Company's Sharesave Plan (the "2022 Sharesave Plan") reached maturity and became capable of exercise.
The Executive Directors listed below exercised their options and acquired Shares at the exercise price of £1.98 per Share on 24 June 2025. All Shares acquired have been retained by the individuals concerned. The exercise price was set at the point of grant and was determined in accordance with the valuation methodology agreed with HM Revenue & Customs and the rules of the 2022 Sharesave Plan.
|
Executive Directors |
Number of Shares acquired |
Exercise Price per Share |
|
Justin Ash |
1,818 |
£1.98 |
|
Harbant Samra |
1,818 |
£1.98 |
Following the transactions, Justin Ash holds 1,300,459 Shares and Harbant Samra holds 55,077 Shares.
Name of contact and telephone number for queries:
Mantraraj Budhdev
Group General Counsel and Company Secretary
Spire Healthcare Group plc
Tel: 07787 283848
The information set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name
|
Justin Ash |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Executive Officer |
|
|
b) |
Initial notification /Amendment
|
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name
|
Spire Healthcare Group plc |
|
|
b) |
LEI |
213800IBJPW3SE2RA350
|
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each
GB00BNLPYF73 |
|
|
b) |
Nature of the transaction |
Exercise of options under the Company's 2022 Sharesave Plan. All shares have been retained. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£1.98 |
1,818 |
||
|
|
|||
|
d) |
Aggregated information - Aggregated volume - Price |
As above |
|
|
e) |
Date of the transaction |
2025-06-24 |
|
|
f) |
Place of the transaction |
Outside of trading venue |
|
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name
|
Harbant Samra |
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Financial Officer |
|
|
b) |
Initial notification /Amendment
|
Initial notification |
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name
|
Spire Healthcare Group plc |
|
|
b) |
LEI |
213800IBJPW3SE2RA350
|
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each
GB00BNLPYF73 |
|
|
b) |
Nature of the transaction |
Exercise of options under the Company's 2022 Sharesave Plan. All shares have been retained. |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£1.98 |
1,818 |
||
|
|
|||
|
d) |
Aggregated information - Aggregated volume - Price |
As above |
|
|
e) |
Date of the transaction |
2025-06-24 |
|
|
f) |
Place of the transaction |
Outside of trading venue |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.